Fatal Adverse Events Associated with Pembrolizumab in Cancer Patients: A Meta-Analysis
Author:
Affiliation:
1. Department of Medicine, Division of Hematology & Oncology, Stony Brook University Hospital, Stony Brook, New York, USA;
2. Department of Medicine, Division of Hematology & Oncology, Northport VA Medical Center, Northport, New York, USA
Publisher
Informa UK Limited
Subject
Cancer Research,Oncology,General Medicine
Link
https://www.tandfonline.com/doi/pdf/10.1080/07357907.2020.1721521
Reference31 articles.
1. Phase I Study of Pembrolizumab (MK-3475; Anti–PD-1 Monoclonal Antibody) in Patients with Advanced Solid Tumors
2. Pembrolizumab for the Treatment of Non–Small-Cell Lung Cancer
3. PD-1 blockade induces responses by inhibiting adaptive immune resistance
4. Cancer immunotherapy using checkpoint blockade
5. Keytruda (pembrolizumab) [package insert]. Carlow, Ireland: Merc Pharmaceutical Companies; 2014–2019.
Cited by 15 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Comparative analysis of adverse event risks in breast cancer patients receiving pembrolizumab combined with paclitaxel versus paclitaxel monotherapy: insights from the FAERS database;Frontiers in Pharmacology;2024-08-21
2. Defining clinically useful biomarkers of immune checkpoint inhibitors in solid tumours;Nature Reviews Cancer;2024-06-12
3. Evaluation of time-to-onset and outcome of cardiac adverse events related to pembrolizumab using post-marketing surveillance in Japanese patients;DARU Journal of Pharmaceutical Sciences;2024-04-26
4. Carpal Tunnel Syndrome Associated with Immune Checkpoint Inhibitors;Journal of Personalized Medicine;2023-08-30
5. Retifanlimab: a breakthrough for the management of Merkel cell carcinoma;International Journal of Surgery Oncology;2023-08-17
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3